These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 16609023)

  • 21. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
    Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
    Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
    Wang XS; Zhang Z; Wang HC; Cai JL; Xu QW; Li MQ; Chen YC; Qian XP; Lu TJ; Yu LZ; Zhang Y; Xin DQ; Na YQ; Chen WF
    Clin Cancer Res; 2006 Aug; 12(16):4851-8. PubMed ID: 16914571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation identifies progression risk in bladder cancer.
    Yates DR; Rehman I; Abbod MF; Meuth M; Cross SS; Linkens DA; Hamdy FC; Catto JW
    Clin Cancer Res; 2007 Apr; 13(7):2046-53. PubMed ID: 17404085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
    Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
    Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
    Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
    Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
    Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer.
    Kinoshita T; Nomoto S; Kodera Y; Koike M; Fujiwara M; Nakao A
    Hepatogastroenterology; 2011; 58(107-108):1051-6. PubMed ID: 21830441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.